REG - Concurrent Tech. - Issue of share options and PDMR dealing

Concurrent TechnologiesAnnouncement

23/06/2021 12:00

RNS Number : 8671C
  
Concurrent Technologies PLC
  
23 June 2021
  
 

23 June 2021
 
Concurrent Technologies Plc
(the 'Company')
 
Issue of share options and PDMR dealing 
 
The Board of Concurrent Technologies Plc (AIM:CNC) announces that, on 22 June, the Company granted share options (the "Share Options") over 267,379 ordinary shares of 1p each in the share capital of the Company to Miles Adcock, the newly appointed Chief Executive Officer and executive director of the Company.
The Share Options have an exercise price, calculated in accordance with the rules of the Enterprise Management Incentive Scheme 2000, of 93.5 pence each.
The Share Options will vest after 3 years and are subject to performance conditions linked to the average basic earnings per Ordinary Share for the complete years commencing with 1st January 2021 and ending with the year ending most immediately prior to the exercise of the Option.
 
Enquiries:
 




Concurrent Technologies Plc

Miles Adcock - CEO


 
+44 (0)1206 752626




 


 




Newgate (Financial PR)

Bob Huxford
Isabelle Smurfit


 
+44 (0)20 7653 9848

+44 (0)20 3757 3411




 


 




Cenkos Securities Plc (NOMAD)

Neil McDonald
Peter Lynch




+44 (0)131 220 9771
+44 (0)131 220 9772




 
Note to Editors:
 
About Concurrent Technologies Plc
 
Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 9th generation embedded Intel® Core™ processors, Intel® Xeon® and Intel® Atom™ processors.  The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems.  The products are sold world-wide.
 
For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.
 
All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.
 




1.


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Miles Adcock




2.


Reason for the Notification




a)


Position/status


Director




b)


Initial notification/amendment


Initial notification




3.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Concurrent Technologies Plc




b)


LEI


213800422HXP2X6UPD94




4.


Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted




a)


Description of the Financial instrument, type of instrument


Ordinary shares of 1 pence each




 


Identification code


GB0002183191




b)


Nature of the Transaction


Grant of Share Options under the approved EMI 2000 scheme




c)


Price(s) and volume(s)


Price(s)


Volume(s)




93.5 pence


267,379 ordinary shares




d)


Aggregated information
Aggregated volume price


N/A - Single Transaction




e)


Date of the transaction


22 June 2021




f)


Place of the transaction


Outside a trading venue




 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHBXLFLFQLEBBE